Max Healthcare Institute Limited (MAXHEALTH): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Max Healthcare Institute Limited, explained in plain English.

• ▪Max Healthcare Institute Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪MAXHEALTH closed at ₹860.00 on 30 October 2026.
• ▪Over the past year the shares are down 27.0%, trading between ₹797.00 and ₹1,189.00.
• ▪Reported fundamentals show a net margin of 16.72%, debt to equity of 32.37.
• ▪Our transparent MaxGrade checklist scores it C (51/100) across momentum, growth, profitability and safety on fixed thresholds.
• ▪Annualised volatility over the past year is 25.96% with a maximum drawdown of -31.0% and a beta of 0.66 against NIFTY 50.
• ▪Recent coverage: Max Healthcare Q2 net profit falls 15.6% on higher operating, tax expenses
• ▪Recent coverage: Max Healthcare Q2 PAT rises 10% to ₹448 cr on higher bed occupancy

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Ajanta Pharmaceuticals, Alkem Laboratories, Anthem Biosciences, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma

Last traded values from 30 Oct 2026. Market closed.